Top

Published in:

01-11-2013 | Original Article

Safety and effects of two red blood cell transfusion strategies in pediatric cardiac surgery patients: a randomized controlled trial

Authors: D. H. de Gast-Bakker, R. B. P. de Wilde, M. G. Hazekamp, V. Sojak, J. J. Zwaginga, R. Wolterbeek, E. de Jonge, B. J. Gesink-van der Veer

Published in: Intensive Care Medicine | Issue 11/2013

Abstract

Objective

To investigate the safety and effects of a restrictive red blood cell (RBC) transfusion strategy in pediatric cardiac surgery patients.

Design

Randomized controlled trial.

Setting

Pediatric ICU in an academic tertiary care center, Leiden University Medical Center, Leiden, The Netherlands.

Patients

One hundred seven patients with non-cyanotic congenital heart defects between 6 weeks and 6 years of age. One hundred three patients underwent corrective surgery on cardiopulmonary bypass.

Interventions

Prior to surgery patients were randomly assigned to one of two groups with specific RBC transfusion thresholds: Hb 10.8 g/dl (6.8 mmol/l) and Hb 8.0 g/dl (5.0 mmol/l).

Measurements

Length of stay in hospital (primary outcome), length of stay in PICU, duration of ventilation (secondary outcome), incidence of adverse events and complications related to randomization (intention to treat analysis).

Results

In the restrictive transfusion group, mean volume of transfused RBC was 186 (±70) ml per patient and in the liberal transfusion group 258 (±87) ml per patient, (95 % CI 40.6–104.6), p < 0.001. Length of hospital stay was shorter in patients with a restrictive RBC transfusion strategy: median 8 (IQR 7–11) vs. 9 (IQR 7–14) days, p = 0.047. All other outcome measures and incidence of adverse effects were equal in both RBC transfusion groups. Cost of blood products for the liberal transfusion group was 438.35 (±203.39) vs. 316.27 (±189.96) euros (95 % CI 46.61–197.51) per patient in the restrictive transfusion group, p = 0.002.

Conclusions

For patients with a non-cyanotic congenital heart defect undergoing elective cardiac surgery, a restrictive RBC transfusion policy (threshold of Hb 8.0 g/dl) during the entire perioperative period is safe, leads to a shorter hospital stay and is less expensive.

Available only for authorised users

Goodman AM, Pollack MM, Patel KM, Luban NL (2003) Pediatric red blood cell transfusions increase resource use. J Pediatr 142:123–127PubMedCrossRef

Hendrickson JE, Hillyer CD (2009) Noninfectious serious hazards of transfusion. Anesth Analg 108:759–769PubMedCrossRef

Chapman CE, Stainsby D, Jones H, Love E, Massey E, Win N, Navarrete C, Lucas G, Soni N, Morgan C, Choo L, Cohen H, Williamson LM (2009) Ten years of haemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion 49:440–452PubMedCrossRef

Baumgartner JM, Silliman CC, Moore EE, Banerjee A, McCarter MD (2009) Stored red blood cell transfusion induces regulatory T cells. J Am Coll Surg 208:110–119PubMedCrossRef

Surgenor SD, Kramer RS, Olmstead EM, Ross CS, Sellke FW, Likosky DS, Marrin CA, Helm RE Jr, Leavitt BJ, Morton JR, Charlesworth DC, Clough RA, Hernandez F, Frumiento C, Benak A, DioData C, O’Connor GT (2009) The association of perioperative red blood cell transfusions and decreased long-term survival after cardiac surgery. Anesth Analg 108:1741–1746PubMedCrossRef

Kneyber MC, Hersi MI, Twisk JW, Markhorst DG, Plotz FB (2007) Red blood cell transfusion in critically ill children is independently associated with increased mortality. Intensive Care Med 33:1414–1422PubMedCrossRef

Kipps AK, Wypij D, Thiagarajan RR, Bacha EA, Newburger JW (2011) Blood transfusion is associated with prolonged duration of mechanical ventilation in infants undergoing reparative cardiac surgery. Pediatr Crit Care Med 12:52–56PubMedCrossRef

Salvin JW, Scheurer MA, Laussen PC, Wypij D, Polito A, Bacha EA, Pigula FA, McGowan FX, Costello JM, Thiagarajan RR (2011) Blood transfusion after pediatric cardiac surgery is associated with prolonged hospital stay. Ann Thorac Surg 91:204–210PubMedCrossRef

Kuduvalli M, Oo AY, Newall N, Grayson AD, Jackson M, Desmond MJ, Fabri BM, Rashid A (2005) Effect of peri-operative red blood cell transfusion on 30-day and 1-year mortality following coronary artery bypass surgery. Eur J Cardiothorac Surg 27:592–598PubMedCrossRef

10.

Mohnle P, Snyder-Ramos SA, Miao Y, Kulier A, Bottiger BW, Levin J, Mangano DT (2011) Postoperative red blood cell transfusion and morbid outcome in uncomplicated cardiac surgery patients. Intensive Care Med 37:97–109PubMedCrossRef

11.

Oliver E, Carrio ML, Rodriguez-Castro D, Javierre C, Farrero E, Torrado H, Castells E, Ventura JL (2009) Relationships among haemoglobin level, packed red cell transfusion and clinical outcomes in patients after cardiac surgery. Intensive Care Med 35:1548–1555PubMedCrossRef

12.

Hajjar LA, Vincent JL, Galas FR, Nakamura RE, Silva CM, Santos MH, Fukushima J, Kalil FR, Sierra DB, Lopes NH, Mauad T, Roquim AC, Sundin MR, Leao WC, Almeida JP, Pomerantzeff PM, Dallan LO, Jatene FB, Stolf NA, Auler JO Jr (2010) Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA 304:1559–1567PubMedCrossRef

13.

Vincent JL, Hajjar LA (2013) What’s new in transfusion policies? Intensive Care Med 39:1002–1004PubMedCrossRef

14.

Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368–1377PubMedCrossRef

15.

Cholette JM, Rubenstein JS, Alfieris GM, Powers KS, Eaton M, Lerner NB (2011) Children with single-ventricle physiology do not benefit from higher hemoglobin levels post cavopulmonary connection: results of a prospective, randomized, controlled trial of a restrictive versus liberal red-cell transfusion strategy. Pediatr Crit Care Med 12:39–45PubMedCrossRef

16.

Willems A, Harrington K, Lacroix J, Biarent D, Joffe AR, Wensley D, Ducruet T, Hebert PC, Tucci M (2010) Comparison of two red-cell transfusion strategies after pediatric cardiac surgery: a subgroup analysis. Crit Care Med 38:649–656PubMedCrossRef

17.

Szekely A, Cserep Z, Sapi E, Breuer T, Nagy CA, Vargha P, Hartyanszky I, Szatmari A, Treszl A (2009) Risks and predictors of blood transfusion in pediatric patients undergoing open heart operations. Ann Thorac Surg 87:187–197PubMedCrossRef

18.

Roseff SD, Luban NL, Manno CS (2002) Guidelines for assessing appropriateness of pediatric transfusion. Transfusion 42:1398–1413PubMedCrossRef

19.

Armano R, Gauvin F, Ducruet T, Lacroix J (2005) Determinants of red blood cell transfusions in a pediatric critical care unit: a prospective, descriptive epidemiological study. Crit Care Med 33:2637–2644PubMedCrossRef

20.

Mhanna MJ, Super DM (2005) What hemoglobin value should one use in transfusing a critically ill child? Crit Care Med 33:2710–2711PubMedCrossRef

21.

Nahum E, Ben Ari J, Schonfeld T (2004) Blood transfusion policy among European pediatric intensive care physicians. J Intensive Care Med 19:38–43PubMedCrossRef

22.

Tweddell JS, Hoffman GM, Fedderly RT, Ghanayem NS, Kampine JM, Berger S, Mussatto KA, Litwin SB (2000) Patients at risk for low systemic oxygen delivery after the Norwood procedure. Ann Thorac Surg 69:1893–1899PubMedCrossRef

23.

Tweddell JS, Hoffman GM (2002) Postoperative management in patients with complex congenital heart disease. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 5:187–205PubMedCrossRef

24.

Tweddell JS, Hoffman GM, Mussatto KA, Fedderly RT, Berger S, Jaquiss RD, Ghanayem NS, Frisbee SJ, Litwin SB (2002) Improved survival of patients undergoing palliation of hypoplastic left heart syndrome: lessons learned from 115 consecutive patients. Circulation 106:I82–I89PubMed

25.

Pearse R, Dawson D, Fawcett J, Rhodes A, Grounds RM, Bennett ED (2005) Changes in central venous saturation after major surgery, and association with outcome. Crit Care 9:R694–R699PubMedCrossRef

26.

Hoffman GM, Mussatto KA, Brosig CL, Ghanayem NS, Musa N, Fedderly RT, Jaquiss RD, Tweddell JS (2005) Systemic venous oxygen saturation after the Norwood procedure and childhood neurodevelopmental outcome. J Thorac Cardiovasc Surg 130:1094–1100PubMedCrossRef

27.

Lacroix J, Hebert PC, Hutchison JS, Hume HA, Tucci M, Ducruet T, Gauvin F, Collet JP, Toledano BJ, Robillard P, Joffe A, Biarent D, Meert K, Peters MJ (2007) Transfusion strategies for patients in pediatric intensive care units. N Engl J Med 356:1609–1619PubMedCrossRef

28.

Rouette J, Trottier H, Ducruet T, Beaunoyer M, Lacroix J, Tucci M (2010) Red blood cell transfusion threshold in postsurgical pediatric intensive care patients: a randomized clinical trial. Ann Surg 251:421–427PubMedCrossRef

29.

Marik PE, Corwin HL (2008) Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. Crit Care Med 36:2667–2674PubMedCrossRef

30.

Desmet L, Lacroix J (2004) Transfusion in pediatrics. Crit Care Clin 20:299–311PubMedCrossRef

31.

Weiskopf RB (1998) Do we know when to transfuse red cells to treat acute anemia? Transfusion 38:517–521PubMedCrossRef

32.

Palmieri TL, Lee T, O’Mara MS, Greenhalgh DG (2007) Effects of a restrictive blood transfusion policy on outcomes in children with burn injury. J Burn Care Res 28:65–70PubMedCrossRef

33.

Jenkins KJ, Gauvreau K, Newburger JW, Spray TL, Moller JH, Iezzoni LI (2002) Consensus-based method for risk adjustment for surgery for congenital heart disease. J Thorac Cardiovasc Surg 123:110–118PubMedCrossRef

34.

Pollack MM, Patel KM, Ruttimann UE (1996) PRISM III: an updated pediatric risk of mortality score. Crit Care Med 24:743–752PubMedCrossRef

35.

Slater A, Shann F, Pearson G (2003) PIM2: a revised version of the paediatric index of mortality. Intensive Care Med 29:278–285PubMed

36.

Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E (1999) A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion requirements in critical care investigators, Canadian critical care trials group. N Engl J Med 340:409–417PubMedCrossRef

Title: Safety and effects of two red blood cell transfusion strategies in pediatric cardiac surgery patients: a randomized controlled trial
Authors: D. H. de Gast-Bakker
R. B. P. de Wilde
M. G. Hazekamp
V. Sojak
J. J. Zwaginga
R. Wolterbeek
E. de Jonge
B. J. Gesink-van der Veer
Publication date: 01-11-2013
Publisher: Springer Berlin Heidelberg
Published in: Intensive Care Medicine / Issue 11/2013
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-013-3085-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Safety and effects of two red blood cell transfusion strategies in pediatric cardiac surgery patients: a randomized controlled trial

Abstract

Objective

Design

Setting

Patients

Interventions

Measurements

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objective

Design

Setting

Patients

Interventions

Measurements

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 11/2013

Syphilitic aortic aneurysm revealed by pericardial tamponade and brain infarction

How objective is the observed mortality following critical care?

Increasing the effective airway diameter on weaning of tracheostomized patients: choosing the right outcome

Extracorporeal membrane oxygenation instead of invasive mechanical ventilation in patients with acute respiratory distress syndrome

Managing the apparent and hidden difficulties of weaning from mechanical ventilation

Characteristics and outcome of children admitted to adult intensive care units in England, Wales and Northern Ireland (1996–2011)